InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the complete record of transactions filed by Scott John K Jr., Director. Director active across 1 company, notably Navidea Biopharmaceuticals, INC.. Cumulatively, 16 filings have been published. Activity tracked since 15 November 2021. The latest transaction was filed on 29 June 2023 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Scott John K Jr.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations16 total
2,270 sharesSeries G Redeemable Preferred StockSEC:0001415889-23-015898:0
12,200,000 shares@ US$0.088100.0% of flowCommon StockSEC:0001437749-23-018979:0
990 sharesSeries G Redeemable Preferred StockSEC:0001437749-23-017587:0
1,250 shares0Common StockSEC:0001437749-22-028197:0
2,500 shares0Common StockSEC:0001437749-22-025387:0
2,500 shares0Common StockSEC:0001437749-22-023610:0
2,500 shares0Common StockSEC:0001437749-22-021740:0
2,500 shares0Common StockSEC:0001437749-22-018283:0
2,500 shares0Common StockSEC:0001437749-22-016603:0
2,500 shares0Common StockSEC:0001437749-22-014045:0
2,500 shares0Common StockSEC:0001437749-22-010726:0
2,500 shares0Common StockSEC:0001437749-22-007860:0
2,500 shares0Common StockSEC:0001437749-22-004850:0
2,500 shares0Common StockSEC:0001437749-22-002110:0
2,500 shares0Common StockSEC:0001437749-22-000324:0
30,000 shares@ US$0.00150.0% of flowCommon StockSEC:0001437749-21-027696:0
16 of 16 declarations
About Scott John K Jr.
John K. Scott Jr. is a Board Member at NAVIDEA BIOPHARMACEUTICALS, INC. As a board member, he contributes to the strategic direction of the company. His experience in the biopharmaceutical sector is valuable in guiding decisions and ensuring regulatory compliance. He plays an active role in evaluating the company's performance and overseeing its operations.
